Sign In
Buy SGHT
$4.34
+0 (+0%)
At Close: Jun 03, 2026
Sight Sciences, Inc. (SGHT) Q4 2025 Earnings Call Transcript
07:02pm, Wednesday, 04'th Mar 2026
Sight Sciences, Inc. (SGHT) Q4 2025 Earnings Call Transcript
Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to Say
07:01pm, Wednesday, 04'th Mar 2026
The headline numbers for Sight Sciences (SGHT) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Stree
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
06:16pm, Wednesday, 04'th Mar 2026
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.23 per share a year ago.
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance
04:05pm, Wednesday, 04'th Mar 2026
MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:01am, Wednesday, 25'th Feb 2026
Sight Sciences (SGHT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
04:05pm, Wednesday, 18'th Feb 2026
MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innov
Americana Partners LLC Grows Stock Holdings in Sight Sciences, Inc. $SGHT
03:27am, Wednesday, 21'st Jan 2026
Americana Partners LLC boosted its stake in shares of Sight Sciences, Inc. (NASDAQ: SGHT) by 42.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Ex
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
07:05am, Tuesday, 13'th Jan 2026
MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innov
Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge
11:29am, Wednesday, 31'st Dec 2025
Sight Sciences surged over 100% after two major Medicare contractors approved coverage for its TearCare dry eye treatment. Positive reimbursement decisions for TearCare open up a sizable market opport
What Makes Sight Sciences, Inc. (SGHT) a Strong Momentum Stock: Buy Now?
01:01pm, Thursday, 18'th Dec 2025
Does Sight Sciences, Inc. (SGHT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Sight Sciences (SGHT) Upgraded to Buy: Here's What You Should Know
01:01pm, Tuesday, 11'th Nov 2025
Sight Sciences (SGHT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sight Sciences, Inc. (SGHT) Q3 2025 Earnings Call Transcript
10:16pm, Thursday, 06'th Nov 2025
Sight Sciences, Inc. ( SGHT ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Paul Badawi - Co-Founder, President, CEO & Director Jim Rodberg - VP of Finance & Corporate Contro
Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
08:31pm, Thursday, 06'th Nov 2025
The headline numbers for Sight Sciences (SGHT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Stre
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
07:55pm, Thursday, 06'th Nov 2025
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.22 per share a year ago.
Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
04:05pm, Thursday, 06'th Nov 2025
MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innov
